Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy

NCT02194998 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

Enrollment

NIH

Sponsor class

Stopped The study closed to accrual before the planned accrual goal was attained due to the availability of newer directly-acting antiviral (DAA) treatments for HCV.

Conditions

HIV Infections
Hepatitis C

Interventions

DRUG: Paritaprevir/ritonavir/ombitasvir (PTV/r/OBT)
DRUG: Dasabuvir (DSV)
DRUG: Ribavirin (RBV)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)